FDA Approves Jemperli/Chemo Regimen for Endometrial Cancer Subset 🔗 Access full article via CureToday Jemperli was approved with chemotherapy and then alone for patients with dMMR or MSI-H advanced endometrial cancer Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon